MARKER THERAPEUTICS, INC. Clearance Fees
MARKER THERAPEUTICS, INC. (MRKR) reported Clearance Fees of $681.79 thousand for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ClearanceFees · last filed 2014-11-19
- MARKER THERAPEUTICS, INC. clearance fees for the quarter ending 2014-09-30 was $681.79K, a 1082.05% increase year-over-year.
- MARKER THERAPEUTICS, INC. clearance fees for the quarter ending 2014-06-30 was $56.32K, a 54.87% increase year-over-year.
- MARKER THERAPEUTICS, INC. clearance fees for the quarter ending 2013-09-30 was $57.68K.
- MARKER THERAPEUTICS, INC. clearance fees for the quarter ending 2013-06-30 was $36.37K.
| Period end | Clearance Fees 3 month | Clearance Fees 6 month | Clearance Fees 9 month | Clearance Fees 179 month |
|---|---|---|---|---|
| 2014-09-30 | $681.79K 10-Q · filed 2014-11-19 | $738.12K derived: sum of 2 quarters · filed 2014-11-19 | $1.56M 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $56.32K 10-Q · filed 2014-08-18 | $91.34K 10-Q · filed 2014-08-18 | $2.50M 10-Q · filed 2014-08-18 | |
| 2013-09-30 | $57.68K 10-Q · filed 2014-11-19 | $94.05K derived: sum of 2 quarters · filed 2014-11-19 | $207.81K 10-Q · filed 2014-11-19 | |
| 2013-06-30 | $36.37K 10-Q · filed 2014-08-18 | $66.37K 10-Q · filed 2014-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |